COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
D. Stolz, R. Louis, W. Boersma, B. Milenkovic, K. Kostikas, F. Blasi, J. Aerts, G. Rohde, A. Marin, L. Boeck, J. Rakic, A. Scherr, A. Torres, T. Welte, M. Tamm (Basel, Switzerland; Alkmaar, Breda, Maastricht, Netherlands; Belgrad, Republic Of Serbia; Thessaloniki, Greece; Milan, Italy; Liege, Belgium; Badalona, Barcelona, Spain; Hannover, Hennigsdorf, Germany)
Source: International Congress 2014 – Markers
Session: Markers
Session type: Thematic Poster Session
Number: 566
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Stolz, R. Louis, W. Boersma, B. Milenkovic, K. Kostikas, F. Blasi, J. Aerts, G. Rohde, A. Marin, L. Boeck, J. Rakic, A. Scherr, A. Torres, T. Welte, M. Tamm (Basel, Switzerland; Alkmaar, Breda, Maastricht, Netherlands; Belgrad, Republic Of Serbia; Thessaloniki, Greece; Milan, Italy; Liege, Belgium; Badalona, Barcelona, Spain; Hannover, Hennigsdorf, Germany). COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study. Eur Respir J 2014; 44: Suppl. 58, 566
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: